1. Home
  2. AMBI vs NKTR Comparison

AMBI vs NKTR Comparison

Compare AMBI & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMBI
  • NKTR
  • Stock Information
  • Founded
  • AMBI 1995
  • NKTR 1990
  • Country
  • AMBI Brazil
  • NKTR United States
  • Employees
  • AMBI N/A
  • NKTR N/A
  • Industry
  • AMBI Environmental Services
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMBI Industrials
  • NKTR Health Care
  • Exchange
  • AMBI Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • AMBI 255.0M
  • NKTR 238.7M
  • IPO Year
  • AMBI N/A
  • NKTR 1994
  • Fundamental
  • Price
  • AMBI $5.37
  • NKTR $1.32
  • Analyst Decision
  • AMBI
  • NKTR Buy
  • Analyst Count
  • AMBI 0
  • NKTR 4
  • Target Price
  • AMBI N/A
  • NKTR $2.50
  • AVG Volume (30 Days)
  • AMBI 6.1K
  • NKTR 988.9K
  • Earning Date
  • AMBI 01-01-0001
  • NKTR 11-05-2024
  • Dividend Yield
  • AMBI N/A
  • NKTR N/A
  • EPS Growth
  • AMBI 3161.09
  • NKTR N/A
  • EPS
  • AMBI 0.56
  • NKTR N/A
  • Revenue
  • AMBI $504,573,816.00
  • NKTR $93,157,000.00
  • Revenue This Year
  • AMBI N/A
  • NKTR N/A
  • Revenue Next Year
  • AMBI N/A
  • NKTR N/A
  • P/E Ratio
  • AMBI $9.32
  • NKTR N/A
  • Revenue Growth
  • AMBI 25.13
  • NKTR 6.17
  • 52 Week Low
  • AMBI $3.07
  • NKTR $0.41
  • 52 Week High
  • AMBI $8.44
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • AMBI 61.12
  • NKTR 56.07
  • Support Level
  • AMBI $4.45
  • NKTR $1.11
  • Resistance Level
  • AMBI $6.02
  • NKTR $1.39
  • Average True Range (ATR)
  • AMBI 0.36
  • NKTR 0.09
  • MACD
  • AMBI 0.15
  • NKTR 0.01
  • Stochastic Oscillator
  • AMBI 74.11
  • NKTR 75.00

About AMBI Ambipar Emergency Response

Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: